285 related articles for article (PubMed ID: 23084023)
1. Trisomy correction in Down syndrome induced pluripotent stem cells.
Li LB; Chang KH; Wang PR; Hirata RK; Papayannopoulou T; Russell DW
Cell Stem Cell; 2012 Nov; 11(5):615-9. PubMed ID: 23084023
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21.
Gonzales PK; Roberts CM; Fonte V; Jacobsen C; Stein GH; Link CD
PLoS One; 2018; 13(3):e0194581. PubMed ID: 29584757
[TBL] [Abstract][Full Text] [Related]
3. A dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction.
Bansal P; Banda EC; Glatt-Deeley HR; Stoddard CE; Linsley JW; Arora N; Deleschaux C; Ahern DT; Kondaveeti Y; Massey RE; Nicouleau M; Wang S; Sabariego-Navarro M; Dierssen M; Finkbeiner S; Pinter SF
Sci Adv; 2024 Jun; 10(23):eadj0385. PubMed ID: 38848354
[TBL] [Abstract][Full Text] [Related]
4. Deficits in human trisomy 21 iPSCs and neurons.
Weick JP; Held DL; Bonadurer GF; Doers ME; Liu Y; Maguire C; Clark A; Knackert JA; Molinarolo K; Musser M; Yao L; Yin Y; Lu J; Zhang X; Zhang SC; Bhattacharyya A
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9962-7. PubMed ID: 23716668
[TBL] [Abstract][Full Text] [Related]
5. iPSC reprogramming-mediated aneuploidy correction in autosomal trisomy syndromes.
Akutsu SN; Miyamoto T; Oba D; Tomioka K; Ochiai H; Ohashi H; Matsuura S
PLoS One; 2022; 17(3):e0264965. PubMed ID: 35271616
[TBL] [Abstract][Full Text] [Related]
6. Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro.
Chiang JC; Jiang J; Newburger PE; Lawrence JB
Nat Commun; 2018 Dec; 9(1):5180. PubMed ID: 30518921
[TBL] [Abstract][Full Text] [Related]
7. [Progress of research on induced pluripotent stem cell models for Down syndrome].
Zhang T; Kong L; Sun G; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1183-1185. PubMed ID: 32924131
[TBL] [Abstract][Full Text] [Related]
8. Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome.
Mou X; Wu Y; Cao H; Meng Q; Wang Q; Sun C; Hu S; Ma Y; Zhang H
Stem Cell Res Ther; 2012 Apr; 3(2):14. PubMed ID: 22512921
[TBL] [Abstract][Full Text] [Related]
9. Trisomy 21-associated increases in chromosomal instability are unmasked by comparing isogenic trisomic/disomic leukocytes from people with mosaic Down syndrome.
Rafferty K; Archer KJ; Turner K; Brown R; Jackson-Cook C
PLoS One; 2021; 16(7):e0254806. PubMed ID: 34283872
[TBL] [Abstract][Full Text] [Related]
10. Generation of two induced pluripotent stem cell lines from patients with Down syndrome.
Zhu W; Liu W; Yu R; Manning M; Waran Romfh A; Wu JC
Stem Cell Res; 2023 Oct; 72():103204. PubMed ID: 37734318
[TBL] [Abstract][Full Text] [Related]
11. Generation of two human iPSC lines (UUIGPi013-A and UUIPGi014-A) from cases with Down syndrome and full trisomy for chromosome 21 (T21).
Schuster J; Hoeber J; Sobol M; Fatima A; Annerén G; Dahl N
Stem Cell Res; 2020 Dec; 49():102081. PubMed ID: 33220594
[TBL] [Abstract][Full Text] [Related]
12. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome.
M Lee Y; Zampieri BL; Scott-McKean JJ; Johnson MW; Costa ACS
Stem Cells Transl Med; 2017 Jun; 6(6):1465-1476. PubMed ID: 28371411
[TBL] [Abstract][Full Text] [Related]
13. Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration.
Murray A; Letourneau A; Canzonetta C; Stathaki E; Gimelli S; Sloan-Bena F; Abrehart R; Goh P; Lim S; Baldo C; Dagna-Bricarelli F; Hannan S; Mortensen M; Ballard D; Syndercombe Court D; Fusaki N; Hasegawa M; Smart TG; Bishop C; Antonarakis SE; Groet J; Nizetic D
Stem Cells; 2015 Jun; 33(6):2077-84. PubMed ID: 25694335
[TBL] [Abstract][Full Text] [Related]
14. N-Acetylcysteine prevents amyloid-β secretion in neurons derived from human pluripotent stem cells with trisomy 21.
Toshikawa H; Ikenaka A; Li L; Nishinaka-Arai Y; Niwa A; Ashida A; Kazuki Y; Nakahata T; Tamai H; Russell DW; Saito MK
Sci Rep; 2021 Aug; 11(1):17377. PubMed ID: 34462463
[TBL] [Abstract][Full Text] [Related]
15. Fertile offspring from sterile sex chromosome trisomic mice.
Hirota T; Ohta H; Powell BE; Mahadevaiah SK; Ojarikre OA; Saitou M; Turner JMA
Science; 2017 Sep; 357(6354):932-935. PubMed ID: 28818972
[TBL] [Abstract][Full Text] [Related]
16. Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology.
Briggs JA; Sun J; Shepherd J; Ovchinnikov DA; Chung TL; Nayler SP; Kao LP; Morrow CA; Thakar NY; Soo SY; Peura T; Grimmond S; Wolvetang EJ
Stem Cells; 2013 Mar; 31(3):467-78. PubMed ID: 23225669
[TBL] [Abstract][Full Text] [Related]
17. A Pair of Maternal Chromosomes Derived from Meiotic Nondisjunction in Trisomy 21 Affects Nuclear Architecture and Transcriptional Regulation.
Omori S; Tanabe H; Banno K; Tsuji A; Nawa N; Hirata K; Kawatani K; Kokubu C; Takeda J; Taniguchi H; Arahori H; Wada K; Kitabatake Y; Ozono K
Sci Rep; 2017 Apr; 7(1):764. PubMed ID: 28396582
[TBL] [Abstract][Full Text] [Related]
18. Autonomous trisomic rescue of Down syndrome cells.
Inoue M; Kajiwara K; Yamaguchi A; Kiyono T; Samura O; Akutsu H; Sago H; Okamoto A; Umezawa A
Lab Invest; 2019 Jun; 99(6):885-897. PubMed ID: 30760866
[TBL] [Abstract][Full Text] [Related]
19. Generation of AAVS1-EGFP reporter cell lines from an isogenic pair of trisomy 21 and euploid human iPSCs.
Sharma V; Nehra S; Singhal N
Stem Cell Res; 2022 Oct; 64():102890. PubMed ID: 35961104
[TBL] [Abstract][Full Text] [Related]
20. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
Olson LE; Richtsmeier JT; Leszl J; Reeves RH
Science; 2004 Oct; 306(5696):687-90. PubMed ID: 15499018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
